Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. (Q37998931)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Greg Knight

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Craig C Earle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Roxanne Cosby

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Natalie Coburn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Youssef Youssef

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Richard Malthaner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Gastrointestinal Cancer Disease Site Group

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

31 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

28-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467061%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

External validation of a measurement tool to assess systematic reviews (AMSTAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Chemotherapy in gastric cancer: a review and updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

The effectiveness of intravenous 5-fluorouracil-containing chemotherapy after curative resection for gastric carcinoma: A systematic review of published randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Survival after radiotherapy in gastric cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Recent advances in multimodal treatment for gastric cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

A four-dimensional CT-based evaluation of techniques for gastric irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-012-0148-3

Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer

21 January 2018

1 reference

12 December 2020

A randomized trial of 5-fluorouracil, leucovorin, cisplatin and epirubicin (PELF) versus 5-fluorouracil, leucovorin and etoposide (ELF) given as adjuvant chemotherapy to patients with resected advanced gastric adenocarcinomas

1 reference

12 December 2020

A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer

1 reference

12 December 2020

Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients

1 reference

12 December 2020

Intrafractional gastric motion and interfractional stomach deformity during radiation therapy

1 reference

12 December 2020

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

1 reference

12 December 2020

Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer

1 reference

12 December 2020

Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma

1 reference

12 December 2020

Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment

1 reference

12 December 2020

Current options in the management of gastrointestinal cancer.

1 reference

12 December 2020

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

12 December 2020

Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial

1 reference

12 December 2020

Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan

1 reference

12 December 2020

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses

1 reference

12 December 2020